Utah Medical Products
UTMD
60 hedge funds and large institutions have $148M invested in Utah Medical Products in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 7 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
86% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 14
38% more capital invested
Capital invested by funds: $107M → $148M (+$40.9M)
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% less funds holding
Funds holding: 62 → 60 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$888K |
| 2 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
+$785K |
| 3 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$735K |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$551K |
| 5 |
Two Sigma Investments
New York
|
+$221K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
-$1.7M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$528K |
| 3 |
RA
Royce & Associates
New York
|
-$233K |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$227K |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$215K |
UTMD Hedge Fund Activity: Q4 2014 in Review
60 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2014, worth a combined $148M — up 38% from $107M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new UTMD positions and 7 closed out — a net gain of 1 holder — while 26 added to existing stakes and 14 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $888K. The largest seller was Morgan Dempsey Capital Management, cutting an estimated $1.7M.
- 60 institutional investors held Utah Medical Products (UTMD) as of Q4 2014, down from 62 in Q3 2014.
- Funds reported $148M of Utah Medical Products stock for Q4 2014, up 38% quarter-over-quarter.
- 8 funds opened new Utah Medical Products positions in Q4 2014 and 7 closed out, a net change of +1 holder.
- The largest Utah Medical Products buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $888K added.
- The largest Utah Medical Products seller in Q4 2014 was Morgan Dempsey Capital Management, an estimated $1.7M sold.
Based on aggregated 13F filings for Q4 2014.